AZNAstraZenecaNot started yet
A Study to Evaluate Surovatamig Combined With R-CHOP in Participants of 18 to < 80 Years of Age With Previously Untreated Large B-cell Lymphoma With IPI Score 2 to 5
Large B-cell Lymphoma
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 3
- Patients
- 1,200 (planned)
- Started
- Dec 22, 2026
- Main results expected
- Sep 2, 2030
- Fully finished
- Sep 1, 2032
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Progression free survival (PFS) as assessed by Blinded Independent Central Review (BICR)
Measured over: Up to 10 years
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT07911553 · record last updated 2026-11-02 · checked 2026-11-09 15:47 UTC